Cities located in Wake County saw FDA inspections of 3 companies in March

James “Jim” Sigg FDA%27s Deputy Commissioner for Operations and Chief Operating Officer - Official Website
James “Jim” Sigg FDA%27s Deputy Commissioner for Operations and Chief Operating Officer - Official Website
0Comments

There were three companies in cities associated with Wake County, North Carolina, that received three FDA inspections in March, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 50% increase over the number of companies inspected in the previous month, when two companies received two inspections.

The companies inspected were involved in the Biologics sector.

All of the companies were in line with FDA regulations, and don’t need to adjust their managing operations or regulatory/administrative actions.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Companies Located in Cities Within Wake County and Their Inspection Results
Company NameArea of BusinessInspection DateResult
American Red CrossBiologics03/18/2024No Action Indicated (NAI)
UNC Healthcare/FertilityBiologics03/19/2024No Action Indicated (NAI)
Veterans Administration Medical Center Laboratory ServiceBiologics03/20/2024No Action Indicated (NAI)



Related

Jennifer Hoponick Redmon, Senior Director, Environmental Health and Water Quality

RTI International highlights risks of PFAS in food and beverage supply chains

RTI International reports on the widespread presence of ‘forever chemicals’ (PFAS) across food supply chains. The organization describes exposure routes through packaging materials and contaminated water sources while outlining current regulations and industry alternatives.

Craig T. Albanese, CEO

Duke Health trial finds immunotherapy delays chemotherapy in advanced colorectal cancer

A new clinical trial from Duke Health shows that first-line immunotherapy may delay or replace chemotherapy in advanced colorectal cancer cases. The findings offer hope for improved quality of life among younger patients facing aggressive forms of the disease.

Hannah Lohman, RTI Research Environmental Engineer

EPA and HHS announce actions to address microplastics in drinking water

The EPA and HHS have announced new efforts targeting microplastics in U.S. drinking water systems. RTI International staff attended as federal officials detailed regulatory plans prioritizing research funding into detection methods, impacts on health, prevention strategies, and laboratory standards.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Durham Reporter.